IBO:CC - Universal Ibogaine Engages Mike Zappy Zapolin as a Strategic Advisor
(TheNewswire)
Calgary, AB – TheNewswire - October 4, 2023 – Universal Ibogaine Inc.( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with amission to deliver medicalized ibogaine-centered addiction care, ispleased to advise that it has engaged and retained Mike “Zappy”Zapolin as a strategic and business development advisor.
Zappy Zapolin is a well-known USA based futurist,entrepreneur, and award-winning filmmaker who is considered one of theforemost experts in psychedelic therapies and companies. He is thedirector behind the award winning film documentaries "The Realityof Truth" and "Lamar Odom: Reborn," both of which focuson Ibogaine as a solution for the addiction epidemic. He began hiscareer on Wall Street, where he became the youngest Vice President inthe history of the investment bank Bear Stearns. He has beenspotting massive trends for decades, such as internet domain names,legal CBD and cannabis, and now the burgeoning psychedeliceconomy.
Nick Karos, UI CEO, noted “we are pleased that Zappyis keen to be involved in aiding us in our mission to further researchinto the use of ibogaine in addiction treatment care, andspecifically, to advance awareness of the benefits of ibogaine andultimately to have it utilized in our planned clinical trial withHealth Canada.”
About UniversalIbogaine Inc.
UI is a life sciences company, with a mission totransform addiction treatment using medicalized ibogaine through aplanned Canadian clinical trial focused on opioid use disorder, andultimately to utilize that treatment protocol globally through plannedfuture licensing agreements. UI is concurrently developing a state of the art holisticaddiction treatment protocol at its Kelburn Recovery Centre (locatednear Winnipeg, Manitoba) that, which when paired with the plannedibogaine detox protocol, is intended to revolutionize the way we treataddiction and drastically improve the lives of individuals andfamilies affected by addiction.
NEITHER THE TSXVENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM ISDEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTSRESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THISRELEASE.
CAUTIONARY STATEMENTREGARDING FORWARD-LOOKING STATEMENTS
?This news release may containforward-looking statements and information. Forward-lookinginformation is frequently characterized by words such ?as"plans", “planned”, "expect","project", "intends", “intended”"will", "believe", "anticipate","estimate", "scheduled",??"potential", or other similar words, or statementsthat certain events or conditions "may", "should"or ??"could" occur. The forward-looking statements andinformation are based on certain key expectations ?and assumptionsmade by UI. Although UI believes that the expectations andassumptions on which the forward-?looking statements are based arereasonable, undue reliance should not be placed on theforward-?looking statements because UI can give no assurance thatthey will prove to be correct.
Since ?forward-looking statementsaddress future events and conditions, by their very nature theyinvolve ?inherent risks and uncertainties. Actual results coulddiffer materially from those currently anticipated ?due to a numberof factors and risks, which include, but are not limited to, risksthat required ?regulatory approvals are not obtained. The reader iscautioned that assumptions used in the ?preparation of suchinformation, although considered reasonable by UI at the time of?preparation, may prove to be incorrect and readers are cautionednot to place undue reliance on ?forward-looking information, whichspeaks only to conditions as of the date hereof. UI does not?undertake any obligation to release publicly any revisions toforward-looking information contained ?herein to reflect events orcircumstances that occur after the date hereof or to reflect the occurrence ?of unanticipatedevents, except as may be required under applicable securities laws.?
For furtherinformation:
Nick Karos, CEO
Universal Ibogaine Inc.
612-309-3527
Nick.Karos@universalibogaine.com
InvestorRelations: Dugan Selkirk,IR Manager
dugan.selkirk@universalibogaine.com
Related Links
Copyright (c) 2023 TheNewswire - All rights reserved.